Metro Pharmaceuticals Private Limited
About Metro Pharmaceuticals Private Limited
Data last updated:
Metro Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 February 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC103605. Its GSTIN is 07AAECM0824H1ZQ (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rohit Mahajan (Whole-Time Director) and Seema Mahajan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at I – 45 Lajpat Nagar – 1, Delhi, India – 110024.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.95 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹6.97 Lakh (net margin 0.8%) and EBITDA of ₹23.9 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹1.28 Cr and satisfied charges of ₹40 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressI – 45 Lajpat Nagar – 1, Delhi, India – 110024
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Metro Pharmaceuticals Private Limited
The main business activity of Metro Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Metro Pharmaceuticals Private Limited FY 2025 filings available
Metro Pharmaceuticals Private Limited reported revenue of ₹8.95 Cr (up 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Metro Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 16% growth in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Metro Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.9 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.97 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Metro Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Metro Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Metro Pharmaceuticals Private Limited
Metro Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axial Pharmaceuticals Private Limited | ₹9.01 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Vadodara, Gujarat, India |
| Bhisaj Pharmaceuticals Private Limited | ₹9 Cr (FY 2025) | •••• | •••• | 167.0% | •••• | Pune, Maharashtra, India |
| Athasis Lifecare Private Limited | ₹8.97 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Vapi, Gujarat, India |
| Leo Formulations Private Limited | ₹8.97 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Sanand, Gujarat, India |
| O.P. Pharma Private Limited | ₹8.96 Cr (FY 2024) | •••• | •••• | 43.0% | •••• | Delhi, India |
| Metro Pharmaceuticals Private Limited this company | ₹8.95 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Delhi, India |
| Empiai Pharmaceuticals Private Limited | ₹8.93 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Vrinda Healthcare Private Limited | ₹8.92 Cr (FY 2024) | •••• | •••• | -1.0% | •••• | New Delhi, Delhi, India |
| North India Pharma Private Limited | ₹8.92 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Delhi, India |
| Kanhangad Links Private Limited | ₹8.91 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Kasaragod, Kerala, India |
| Triveni Meditech Private Limited | ₹8.91 Cr (FY 2019) | •••• | •••• | -9.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Metro Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Metro Pharmaceuticals Private Limited
Metro Pharmaceuticals Private Limited is audited by SUNNY AGARWAL & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SUNNY AGARWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Metro Pharmaceuticals Private Limited
Metro Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Mahajan | Whole-Time Director | 04 Feb 2000 | 26 Years 8 Months | Current |
| Seema Mahajan Also directs: Krishnaom Foods LLP | Director | 19 Dec 2018 | 7 Years 9 Months | Current |
Ownership and Shareholding of Metro Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Metro Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2013 | Hdfc Bank Limited | ₹1.28 Cr | Open |
| 08 Mar 2022 | Others | ₹14 Lakh | Satisfied |
| 26 Mar 2011 | Canara Bank | ₹8 Lakh | Satisfied |
| 28 Jan 2005 | State Bank of India | ₹15 Lakh | Satisfied |
| 09 Mar 2002 | Bank of Baroda | ₹3 Lakh | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Metro Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Metro Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Metro Pharmaceuticals Private Limited
Metro Pharmaceuticals Private Limited has 8 board changes on record since 2000: 3 appointments and 5 cessations. The latest: Neelam Gupta ceased to be Director on 06 May 2025.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Metro Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Metro Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Metro Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Metro Pharmaceuticals Private Limited
Metro Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECM0824H1ZQ | Delhi | Active | 28 Aug 2019 |
| 09AAECM0824H1ZM | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Metro Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metro Pharmaceuticals Private Limited
Metro Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 February 2000 (26+ years old) and is registered under CIN U24239DL2000PTC103605.
Metro Pharmaceuticals reported revenue of ₹8.95 Cr for FY 2024 (up 16% YoY).
Metro Pharmaceuticals has 2 current directors:
- Rohit Mahajan - Whole-Time Director
- Seema Mahajan - Director
Metro Pharmaceuticals reported a net profit of ₹6.97 Lakh (net margin 0.8%) and EBITDA of ₹23.9 Lakh (EBITDA margin 2.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Metro Pharmaceuticals is 8% over three years and 5% over five years. In the latest year (FY 2024) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Metro Pharmaceuticals is 07AAECM0824H1ZQ, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAECM0824H1ZM (Uttar Pradesh).
The CIN (Corporate Identification Number) of Metro Pharmaceuticals is U24239DL2000PTC103605. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metro Pharmaceuticals was incorporated on 04 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Metro Pharmaceuticals by revenue are Axial Pharmaceuticals Private Limited, Bhisaj Pharmaceuticals Private Limited, Athasis Lifecare Private Limited, Leo Formulations Private Limited, O.P. Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Neelam Gupta ceased to be Director on 06 May 2025. Gagan Gupta ceased to be Director on 01 Nov 2022. Seema Mahajan was appointed as Director on 19 Dec 2018. Metro Pharmaceuticals has 8 board changes on record in total.
The registered office of Metro Pharmaceuticals is at I – 45 Lajpat Nagar – 1, Delhi, India – 110024.